Nivolumab Inj-40,Nivolumab Inj-100,Daratumumab Inj-00mg,Daratumumab Inj400mg,Methotrexate Inj.15,Vi
Key dates
Published
23 Oct 2026, 03:21 PM IST
Bid submission starts
23 Oct 2026, 03:21 PM IST
Bid submission ends
Bids open
14 Nov 2026, 04:00 PM IST
Eligibility and documents required
Work description
52350 × Nivolumab Inj-40 , Nivolumab Inj-100 , Daratumumab Inj- 00mg , Daratumumab Inj400mg , Methotrexate Inj.15 , Vincristine Sulph1 , Vinblastine Inj10 , Mirabegron CapsTab. 50mg , Mirabegron 50mg Silodosin 8mg , Mirabegron 50mg Solifenacin 5mg , Bleomycin Inj.15 , Vinorelbine Inj. 10 , Methotrexate Inj. 500mg , Midazolam Nasal Spray 0.5mg. , Calcitonin Salmon Nasal Spray 200IU , Botulinum A Toxin Inj 100IU , Inj Topotecan 2.5mg , InjCytarabine 1gm , Inj Daunorubicine 20mg , Tab Nitisinone 5mg , Tab Nitisinone 10mg , TabLenvatinib 4mg , Tab Cyclophosphamide , Inj Ifosfamide 1gm , Inj Mesna 200mg , In Dacrbazine 200mg
Tender documents
- GEM-2026-B-8149102.pdfGeM bid document
Download documents here with a free account, or from the portal itself. Create free account
Tender details
- Tender ID
- GEM/2026/B/8149102
- Portal
- Government e-Marketplace (GeM)
- Tender type
- GeM Bid
- Form of contract
- Item wise evaluation
- Product category
- Nivolumab Inj-40,Nivolumab Inj-100,Daratumumab Inj-00mg,Daratumumab Inj400mg,Methotrexate Inj.15,Vi
- Inviting authority
- Esic Medical College & Hospital, Nh-3, Faridabad